Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 47

1.

Grey and White Matter Clinico-Anatomical Correlates of Disinhibition in Neurodegenerative Disease.

Santillo AF, Lundblad K, Nilsson M, Landqvist Waldö M, van Westen D, Lätt J, Blennow Nordström E, Vestberg S, Lindberg O, Nilsson C.

PLoS One. 2016 Oct 10;11(10):e0164122. doi: 10.1371/journal.pone.0164122. eCollection 2016.

2.
3.

Multimodality imaging of Alzheimer disease and other neurodegenerative dementias.

Nasrallah IM, Wolk DA.

J Nucl Med. 2014 Dec;55(12):2003-11. doi: 10.2967/jnumed.114.141416. Epub 2014 Nov 20. Review.

4.

Therapeutic and diagnostic challenges for frontotemporal dementia.

D'Alton S, Lewis J.

Front Aging Neurosci. 2014 Aug 19;6:204. doi: 10.3389/fnagi.2014.00204. eCollection 2014. Review.

5.

White matter tract damage in the behavioral variant of frontotemporal and corticobasal dementia syndromes.

Tovar-Moll F, de Oliveira-Souza R, Bramati IE, Zahn R, Cavanagh A, Tierney M, Moll J, Grafman J.

PLoS One. 2014 Jul 23;9(7):e102656. doi: 10.1371/journal.pone.0102656. eCollection 2014.

6.

Are frontal cognitive and atrophy patterns different in PSP and bvFTD? A comparative neuropsychological and VBM study.

Lagarde J, Valabrègue R, Corvol JC, Pineau F, Le Ber I, Vidailhet M, Dubois B, Levy R.

PLoS One. 2013 Nov 20;8(11):e80353. doi: 10.1371/journal.pone.0080353. eCollection 2013.

7.

Amyloid imaging in atypical presentations of Alzheimer's disease.

Wolk DA.

Curr Neurol Neurosci Rep. 2013 Dec;13(12):412. doi: 10.1007/s11910-013-0412-x. Review.

8.

Efficacy of electroconvulsive therapy for comorbid frontotemporal dementia with bipolar disorder.

Paul S, Goetz J, Bennett J, Korah T.

Case Rep Psychiatry. 2013;2013:124719. doi: 10.1155/2013/124719. Epub 2013 May 12.

9.

The human frontal lobes and frontal network systems: an evolutionary, clinical, and treatment perspective.

Hoffmann M.

ISRN Neurol. 2013;2013:892459. doi: 10.1155/2013/892459. Epub 2013 Mar 14.

10.

Cerebrospinal fluid biomarkers for differentiation of frontotemporal lobar degeneration from Alzheimer's disease.

Irwin DJ, Trojanowski JQ, Grossman M.

Front Aging Neurosci. 2013 Feb 21;5:6. doi: 10.3389/fnagi.2013.00006. eCollection 2013.

11.

Corticospinal tract degeneration associated with TDP-43 type C pathology and semantic dementia.

Josephs KA, Whitwell JL, Murray ME, Parisi JE, Graff-Radford NR, Knopman DS, Boeve BF, Senjem ML, Rademakers R, Jack CR Jr, Petersen RC, Dickson DW.

Brain. 2013 Feb;136(Pt 2):455-70. doi: 10.1093/brain/aws324. Epub 2013 Jan 28.

12.

Clinicopathologic differences among patients with behavioral variant frontotemporal dementia.

Mendez MF, Joshi A, Tassniyom K, Teng E, Shapira JS.

Neurology. 2013 Feb 5;80(6):561-8. doi: 10.1212/WNL.0b013e3182815547. Epub 2013 Jan 16.

13.

The GGGGCC repeat expansion in C9ORF72 in a case with discordant clinical and FDG-PET findings: PET trumps syndrome.

Adeli A, Savica R, Lowe VJ, Vemuri P, Knopman DS, Dejesus-Hernandez M, Rademakers R, Fields JA, Crum BA, Jack CR, Petersen RC, Boeve BF.

Neurocase. 2014;20(1):110-20. doi: 10.1080/13554794.2012.732090. Epub 2012 Nov 30.

14.

Presenilin-1 adopts pathogenic conformation in normal aging and in sporadic Alzheimer's disease.

Wahlster L, Arimon M, Nasser-Ghodsi N, Post KL, Serrano-Pozo A, Uemura K, Berezovska O.

Acta Neuropathol. 2013 Feb;125(2):187-99. doi: 10.1007/s00401-012-1065-6. Epub 2012 Nov 9.

15.

The frontal-anatomic specificity of design fluency repetitions and their diagnostic relevance for behavioral variant frontotemporal dementia.

Possin KL, Chester SK, Laluz V, Bostrom A, Rosen HJ, Miller BL, Kramer JH.

J Int Neuropsychol Soc. 2012 Sep;18(5):834-44. doi: 10.1017/S1355617712000604. Epub 2012 Jul 27.

16.

Asparaginyl endopeptidase cleaves TDP-43 in brain.

Herskowitz JH, Gozal YM, Duong DM, Dammer EB, Gearing M, Ye K, Lah JJ, Peng J, Levey AI, Seyfried NT.

Proteomics. 2012 Aug;12(15-16):2455-63. doi: 10.1002/pmic.201200006.

17.

Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases.

Coppola G, Chinnathambi S, Lee JJ, Dombroski BA, Baker MC, Soto-Ortolaza AI, Lee SE, Klein E, Huang AY, Sears R, Lane JR, Karydas AM, Kenet RO, Biernat J, Wang LS, Cotman CW, Decarli CS, Levey AI, Ringman JM, Mendez MF, Chui HC, Le Ber I, Brice A, Lupton MK, Preza E, Lovestone S, Powell J, Graff-Radford N, Petersen RC, Boeve BF, Lippa CF, Bigio EH, Mackenzie I, Finger E, Kertesz A, Caselli RJ, Gearing M, Juncos JL, Ghetti B, Spina S, Bordelon YM, Tourtellotte WW, Frosch MP, Vonsattel JP, Zarow C, Beach TG, Albin RL, Lieberman AP, Lee VM, Trojanowski JQ, Van Deerlin VM, Bird TD, Galasko DR, Masliah E, White CL, Troncoso JC, Hannequin D, Boxer AL, Geschwind MD, Kumar S, Mandelkow EM, Wszolek ZK, Uitti RJ, Dickson DW, Haines JL, Mayeux R, Pericak-Vance MA, Farrer LA; Alzheimer's Disease Genetics Consortium, Ross OA, Rademakers R, Schellenberg GD, Miller BL, Mandelkow E, Geschwind DH.

Hum Mol Genet. 2012 Aug 1;21(15):3500-12. doi: 10.1093/hmg/dds161. Epub 2012 May 3.

18.

Saccade abnormalities in autopsy-confirmed frontotemporal lobar degeneration and Alzheimer disease.

Boxer AL, Garbutt S, Seeley WW, Jafari A, Heuer HW, Mirsky J, Hellmuth J, Trojanowski JQ, Huang E, DeArmond S, Neuhaus J, Miller BL.

Arch Neurol. 2012 Apr;69(4):509-17. doi: 10.1001/archneurol.2011.1021.

19.

Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics.

Whitwell JL, Weigand SD, Boeve BF, Senjem ML, Gunter JL, DeJesus-Hernandez M, Rutherford NJ, Baker M, Knopman DS, Wszolek ZK, Parisi JE, Dickson DW, Petersen RC, Rademakers R, Jack CR Jr, Josephs KA.

Brain. 2012 Mar;135(Pt 3):794-806. doi: 10.1093/brain/aws001.

20.

Amyloid imaging in dementias with atypical presentation.

Wolk DA, Price JC, Madeira C, Saxton JA, Snitz BE, Lopez OL, Mathis CA, Klunk WE, DeKosky ST.

Alzheimers Dement. 2012 Sep;8(5):389-98. doi: 10.1016/j.jalz.2011.07.003. Epub 2012 Jan 30.

Supplemental Content

Support Center